Clinic
Premium Health, INC.
Premium Health, INC. was paid $85.47M by Medicaid between Jan 2018 and Dec 2024, across 90 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 57% of everything it billed.
33Billing provider infoPREMIUM HEALTH, INC.
BROOKLYN, NY 11230
BROOKLYN, NY 11230
33aNPI1609129402assigned 10/18/2012
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$85.47M
24GClaims710,112
24DCodes billed90
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in New York
Rank by total paid#3 of 158
Median peer was paid$1.73M
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 36,744 | $4.50M | |
| 2019 | 45,083 | $5.89M | |
| 2020 | 45,659 | $6.98M | |
| 2021 | 65,680 | $8.22M | |
| 2022 | 55,332 | $4.24M | |
| 2023 | 203,882 | $19.27M | |
| 2024incomplete | 257,732 | $36.37M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 57% | 328,540 | 187,393 | $49.03M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 7.2% | 38,917 | 10,483 | $6.15M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.9% | 36,930 | 24,089 | $5.93M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.2% | 35,727 | 19,494 | $5.32M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.0% | 19,100 | 11,883 | $2.56M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.3% | 13,632 | 7,997 | $2.01M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.3% | 11,925 | 7,957 | $1.98M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.3% | 13,441 | 9,591 | $1.95M |
| 76830 | Ultrasound, transvaginal | 1.4% | 22,208 | 11,581 | $1.23M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.3% | 7,505 | 5,194 | $1.08M |
| 0501F | 1.0% | 4,182 | 2,715 | $895K | |
| 17110 | <1% | 5,981 | 4,018 | $826K |
78 more codes
| G0467 | Community health center visit, returning patient | <1% | 9,625 | $824K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 5,127 | $774K |
| 81001 | <1% | 13,073 | $618K | |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 243 | $525K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 19,215 | $403K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,424 | $378K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 3,906 | $316K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 40,473 | $291K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 2,714 | $279K |
| 0502F | <1% | 1,295 | $235K | |
| 99443 | <1% | 924 | $180K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 908 | $180K |
| 99205 | Prolong outpt/office vis | <1% | 724 | $138K |
| 99385 | <1% | 883 | $130K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 778 | $116K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,308 | $116K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 841 | $111K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 729 | $110K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,000 | $92K |
| 93000 | <1% | 2,290 | $82K | |
| 99243 | <1% | 346 | $72K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 591 | $72K |
| 99441 | <1% | 264 | $56K | |
| 99442 | <1% | 249 | $54K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 353 | $53K |
| 90710 | <1% | 1,031 | $39K | |
| 69210 | <1% | 983 | $33K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 30,401 | $24K |
| 99383 | <1% | 157 | $23K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 840 | $22K |
| 11102 | <1% | 177 | $18K | |
| 11900 | <1% | 544 | $18K | |
| 0503F | <1% | 48 | $12K | |
| 99382 | <1% | 76 | $11K | |
| 99384 | <1% | 75 | $11K | |
| 99381 | <1% | 58 | $11K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 871 | $9K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 285 | $9K |
| 83655 | <1% | 716 | $8K | |
| 90461 | <1% | 4,762 | $8K | |
| 90674 | <1% | 254 | $7K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 30 | $6K |
| 99386 | <1% | 30 | $4K | |
| 12011 | <1% | 22 | $4K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 85 | $4K |
| 90677 | <1% | 230 | $3K | |
| 76801 | <1% | 28 | $3K | |
| 0012A | <1% | 101 | $3K | |
| 90700 | <1% | 49 | $3K | |
| 58340 | <1% | 14 | $3K | |
| 90661 | <1% | 162 | $3K | |
| 90715 | <1% | 66 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 38 | $2K |
| 90697 | <1% | 1,410 | $2K | |
| 0011A | <1% | 87 | $1K | |
| 76970 | <1% | 22 | $1K | |
| 0064A | <1% | 22 | $845.84 | |
| 76831 | <1% | 14 | $756.92 | |
| 11100 | <1% | 12 | $675.28 | |
| 90686 | <1% | 923 | $372.93 | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 51 | $296.35 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 212 | $102.62 |
| 90685 | <1% | 55 | $64.23 | |
| 81003 | <1% | 24 | $44.16 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 212 | $42.28 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 15 | $25.50 |
| 90670 | <1% | 498 | $17.85 | |
| 90658 | <1% | 19 | $16.40 | |
| 83026 | <1% | 13 | $16.40 | |
| 36416 | <1% | 7,850 | $15.90 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 14 | $0.42 |
| 91301 | 0% | 63 | $0.00 | |
| 90744 | 0% | 12 | $0.00 | |
| 90619 | 0% | 121 | $0.00 | |
| 91306 | 0% | 13 | $0.00 | |
| 90671 | 0% | 909 | $0.00 | |
| 90707 | 0% | 13 | $0.00 | |
| 90633 | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRODY, MEIR (CEO)